Join us on Jan. 9 as Catalyst President Nancy Bradish Myers speaks as part of a panel entitled “Once the train has left the station, is it possible to regulate?” at the Digital Medicine & MedTech Showcase. The panel will explore the use of digital tools, such as mobile apps and wearables, new capabilities offered by technologies such as AI and machine learning, and how the regulatory environment may affect digital health overall.
Ms. Myers will join fellow panelists Mylea Charvat, CEO/Founder, Savonix; Michelle Jump, Principal Regulatory Affairs Specialist, Stryker, and Beth Rogozinski, Chief Content Officer, Pear Therapeutics.